SV2003000741A - Compuesto lactamico x-13170 - Google Patents
Compuesto lactamico x-13170Info
- Publication number
- SV2003000741A SV2003000741A SV2001000741A SV2001000741A SV2003000741A SV 2003000741 A SV2003000741 A SV 2003000741A SV 2001000741 A SV2001000741 A SV 2001000741A SV 2001000741 A SV2001000741 A SV 2001000741A SV 2003000741 A SV2003000741 A SV 2003000741A
- Authority
- SV
- El Salvador
- Prior art keywords
- lactamic
- compound
- procedures
- prepare
- methyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 239000013078 crystal Substances 0.000 abstract 1
- 150000004683 dihydrates Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Abstract
LA PRESENTE INVENCION PROPORCIONA DIHIDRATO CRISTALINO DE(N)-(S) -2-HIDROXI-3-METIL -BUTIRIL)-1-AMINO-3-METIL-4-,5,6,7- TETRAHIDRO-2H-3-BENZOAZEPIN -2-ONA, COMPOSICIONES DEL MISMO Y PROCEDIMIENTOS PARA PREPARARLO Y PROCEDIMIENTOS PARA PREPARAR SUS INTERMEDIOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24965600P | 2000-11-17 | 2000-11-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2003000741A true SV2003000741A (es) | 2003-01-13 |
Family
ID=22944436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2001000741A SV2003000741A (es) | 2000-11-17 | 2001-11-16 | Compuesto lactamico x-13170 |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US20040248878A1 (es) |
| EP (1) | EP1353910B1 (es) |
| JP (1) | JP4116431B2 (es) |
| KR (1) | KR20030045194A (es) |
| CN (2) | CN100516047C (es) |
| AR (1) | AR031356A1 (es) |
| AT (1) | ATE362919T1 (es) |
| AU (2) | AU2002224321B2 (es) |
| BR (1) | BR0115424A (es) |
| CA (1) | CA2425497C (es) |
| CY (1) | CY1106682T1 (es) |
| CZ (1) | CZ20031340A3 (es) |
| DE (1) | DE60128587T2 (es) |
| DK (1) | DK1353910T3 (es) |
| DZ (1) | DZ3454A1 (es) |
| EA (1) | EA006919B1 (es) |
| EC (1) | ECSP034598A (es) |
| ES (1) | ES2286162T3 (es) |
| HR (1) | HRP20030385A2 (es) |
| HU (1) | HUP0301862A3 (es) |
| IL (1) | IL155275A0 (es) |
| MX (1) | MXPA03004250A (es) |
| MY (1) | MY141607A (es) |
| NO (1) | NO325217B1 (es) |
| PE (1) | PE20020798A1 (es) |
| PL (1) | PL211018B1 (es) |
| PT (1) | PT1353910E (es) |
| SK (1) | SK287794B6 (es) |
| SV (1) | SV2003000741A (es) |
| TW (1) | TWI235151B (es) |
| UA (1) | UA77165C2 (es) |
| WO (1) | WO2002040451A2 (es) |
| ZA (1) | ZA200303411B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA74849C2 (en) * | 2000-11-17 | 2006-02-15 | Lilly Co Eli | Lactam |
| MXPA05006567A (es) | 2002-12-20 | 2005-08-16 | Glaxo Group Ltd | Derivados de benzazepina para el tratamiento de trastornos neurologicos. |
| CN102558155A (zh) | 2003-01-14 | 2012-07-11 | 阿伦纳药品公司 | 作为代谢调节剂的芳基和杂芳基衍生物及其所涉及的疾病如糖尿病和高血糖症的预防和治疗 |
| AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
| RU2404968C2 (ru) | 2005-04-08 | 2010-11-27 | Дайити Санкио Компани, Лимитед | Пиридилдиметилсульфоновое производное |
| JP5198877B2 (ja) * | 2006-01-31 | 2013-05-15 | 株式会社エーピーアイ コーポレーション | ベンゾアゼピノン類の製造方法 |
| TW200920362A (en) | 2007-09-11 | 2009-05-16 | Daiichi Sankyo Co Ltd | Alkylsulfone derivatives |
| FR2932800B1 (fr) * | 2008-06-20 | 2015-02-20 | Servier Lab | Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| EA201390421A1 (ru) | 2010-09-22 | 2013-09-30 | Арена Фармасьютикалз, Инк. | Модуляторы рецептора gpr119 и лечение связанных с ним нарушений |
| KR101899014B1 (ko) | 2012-01-06 | 2018-09-17 | 삼성전자주식회사 | 비엘디씨 모터의 제어 장치 및 그 방법 |
| CN102690231B (zh) * | 2012-04-11 | 2014-07-09 | 南京友杰医药科技有限公司 | 治疗阿尔茨海默病潜在药物司马西特的合成方法 |
| WO2014171434A1 (ja) | 2013-04-19 | 2014-10-23 | 国立大学法人岡山大学 | アミロイドβ蛋白質により誘発される認知障害の治療剤およびアルツハイマー病治療薬、ならびにこれらに関連する治療方法および病態解析方法 |
| EP4445956A3 (en) | 2015-01-06 | 2024-12-04 | Arena Pharmaceuticals, Inc. | Compound for use in treating conditions related to the s1p1 receptor |
| PL3310760T3 (pl) | 2015-06-22 | 2023-03-06 | Arena Pharmaceuticals, Inc. | Krystaliczna sól L-argininy kwasu (R)-2-(7-(4-cyklopentylo-3-(trifluorometylo)benzyloksy)- 1,2,3,4-tetrahydrocyklo-penta[b]indol-3-ilo)octowego do zastosowania w zaburzeniach związanych z receptorem S1P1 |
| CN110520124A (zh) | 2017-02-16 | 2019-11-29 | 艾尼纳制药公司 | 用于治疗原发性胆汁性胆管炎的化合物和方法 |
| CA3102136A1 (en) | 2018-06-06 | 2019-12-12 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the s1p1 receptor |
| IL296723A (en) | 2020-03-26 | 2022-11-01 | Seagen Inc | Methods of treating multiple myeloma |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP970705A2 (en) * | 1996-12-23 | 1998-10-31 | Warren J. Porter | CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING "beta" -AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| CA2324474A1 (en) * | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| WO2001034571A1 (en) * | 1999-11-09 | 2001-05-17 | Eli Lilly And Company | β-AMINOACID COMPOUNDS USEFUL FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS |
-
2001
- 2001-02-11 UA UA2003054406A patent/UA77165C2/uk unknown
- 2001-11-02 HU HU0301862A patent/HUP0301862A3/hu unknown
- 2001-11-02 JP JP2002542779A patent/JP4116431B2/ja not_active Expired - Fee Related
- 2001-11-02 EP EP01996530A patent/EP1353910B1/en not_active Expired - Lifetime
- 2001-11-02 CN CNB018189962A patent/CN100516047C/zh not_active Expired - Fee Related
- 2001-11-02 CA CA2425497A patent/CA2425497C/en not_active Expired - Fee Related
- 2001-11-02 US US10/415,548 patent/US20040248878A1/en not_active Abandoned
- 2001-11-02 MX MXPA03004250A patent/MXPA03004250A/es active IP Right Grant
- 2001-11-02 BR BR0115424-9A patent/BR0115424A/pt not_active Application Discontinuation
- 2001-11-02 DE DE60128587T patent/DE60128587T2/de not_active Expired - Lifetime
- 2001-11-02 CN CN200910203885A patent/CN101624372A/zh active Pending
- 2001-11-02 PT PT01996530T patent/PT1353910E/pt unknown
- 2001-11-02 AU AU2002224321A patent/AU2002224321B2/en not_active Ceased
- 2001-11-02 EA EA200300579A patent/EA006919B1/ru unknown
- 2001-11-02 ES ES01996530T patent/ES2286162T3/es not_active Expired - Lifetime
- 2001-11-02 DZ DZ013454A patent/DZ3454A1/fr active
- 2001-11-02 HR HR20030385A patent/HRP20030385A2/hr not_active Application Discontinuation
- 2001-11-02 SK SK543-2003A patent/SK287794B6/sk not_active IP Right Cessation
- 2001-11-02 PL PL360991A patent/PL211018B1/pl unknown
- 2001-11-02 CZ CZ20031340A patent/CZ20031340A3/cs unknown
- 2001-11-02 AU AU2432102A patent/AU2432102A/xx active Pending
- 2001-11-02 KR KR10-2003-7006660A patent/KR20030045194A/ko not_active Ceased
- 2001-11-02 DK DK01996530T patent/DK1353910T3/da active
- 2001-11-02 AT AT01996530T patent/ATE362919T1/de active
- 2001-11-02 WO PCT/US2001/027795 patent/WO2002040451A2/en not_active Ceased
- 2001-11-02 IL IL15527501A patent/IL155275A0/xx unknown
- 2001-11-15 AR ARP010105339A patent/AR031356A1/es not_active Application Discontinuation
- 2001-11-15 TW TW090128351A patent/TWI235151B/zh not_active IP Right Cessation
- 2001-11-15 MY MYPI20015251A patent/MY141607A/en unknown
- 2001-11-16 SV SV2001000741A patent/SV2003000741A/es unknown
- 2001-11-16 PE PE2001001143A patent/PE20020798A1/es not_active Application Discontinuation
-
2003
- 2003-05-02 ZA ZA200303411A patent/ZA200303411B/en unknown
- 2003-05-13 EC EC2003004598A patent/ECSP034598A/es unknown
- 2003-05-15 NO NO20032215A patent/NO325217B1/no unknown
-
2007
- 2007-06-28 CY CY20071100848T patent/CY1106682T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV2003000741A (es) | Compuesto lactamico x-13170 | |
| CR7182A (es) | Benzoilsufanamidas y sulfonilbenzamidinas que se usan como agentes antitumorales | |
| AR026163A1 (es) | Utilizacion de retigabina para el tratamiento de dolores neuropaticos | |
| HN1999000089A (es) | Formulaciones de ziprasidona | |
| DE60135919D1 (de) | Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivate | |
| CY1106132T1 (el) | Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου | |
| SE0000540D0 (sv) | New compounds | |
| BR0215405A (pt) | Composições e processos de uso de collajolie | |
| PA8583401A1 (es) | Nuevos compuestos de triazol como inhibidores del factor de crecimiento transformante (tgf) | |
| BR0113798A (pt) | Derivados de resorcinol | |
| SE0301653D0 (sv) | Novel compounds | |
| BR0211761A (pt) | depsipeptìdeos e processos para preparar os mesmos | |
| SE9901077D0 (sv) | Novel use | |
| GT200600199A (es) | Diarilsulfonas sulfonamidas y su uso | |
| CY1105009T1 (el) | Συνθεση καχαλαλιδης f | |
| DK1105114T3 (da) | Nimesulidholdige topiske farmaceutiske sammensætninger | |
| SE9801494D0 (sv) | Novel use | |
| SE0102716D0 (sv) | Novel compounds | |
| CR7956A (es) | Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos | |
| GT200000035AA (es) | Derivados de resorcinol, (solicitud fraccionaria no. 1 derivada de la patente pi-2000-0035) | |
| UA88867C2 (ru) | Композиция, которая содержит модафинил, и ее применение | |
| BRPI0416678A (pt) | pirazolpirimidinas | |
| DK1492501T3 (da) | Fremgangsmåder med anvendelse af lamellare legemer til terapeutiske formål | |
| HN2000000056A (es) | Nuevas formas cristalinas de un antibiotico macrolido | |
| SV2004001370A (es) | Compuestos basicos lineales que tienen actividad antagonista de nk-2 y sus formulaciones |